LENZ Therapeutics (LENZ) Treasury Shares (2021 - 2025)

LENZ Therapeutics (LENZ) has 4 years of Treasury Shares data on file, last reported at $27640.0 in Q4 2025.

• Treasury Shares for Q4 2025 came in at $27640.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $27640.0 (changed N/A YoY), and the FY2025 annual result was $27640.0, changed N/A from the prior year.
• Treasury Shares eased to $27640.0 in Q4 2025 per LENZ's latest filing, from $152694.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $624845.0 in Q2 2021 and troughed at -$624845.0 in Q4 2021.
• A 4-year average of $80656.7 and a median of $152694.0 in 2023 frame the typical range for Treasury Shares.
• On a YoY basis, Treasury Shares climbed as much as 93.59% in 2023 and fell as far as 93.59% in 2023.
• A 4-year view of Treasury Shares shows it stood at -$624845.0 in 2021, then surged by 112.62% to $78875.0 in 2022, then soared by 93.59% to $152694.0 in 2023, then sank by 81.9% to $27640.0 in 2025.
• Business Quant data shows LENZ's Treasury Shares at $27640.0 in Q4 2025, $152694.0 in Q4 2023, and $152694.0 in Q3 2023.